RadiotherapyPelvic NeoplasmsPelvisRadiotherapy, AdjuvantRadiotherapy DosageRadiation InjuriesAdjuvants, ImmunologicChemotherapy, AdjuvantCombined Modality TherapyAntidiarrhealsRectal NeoplasmsRadiotherapy, ConformalBrachytherapyFreund's AdjuvantRadiation DosageTreatment OutcomeUterine Cervical NeoplasmsRadiation, IonizingDose-Response Relationship, RadiationRadiotherapy, Intensity-ModulatedAntineoplastic Combined Chemotherapy ProtocolsNeoplasm StagingDisease-Free SurvivalRadiotherapy Planning, Computer-AssistedCisplatinRadiation ToleranceRadiotherapy, High-EnergyDose FractionationAdenocarcinomaRadiation OncologyAdjuvants, PharmaceuticRadiationRadiotherapy, Computer-AssistedNeoplasm Recurrence, LocalBreast NeoplasmsRadiotherapy, Image-GuidedRadiation ProtectionRadiation MonitoringSurvival AnalysisTime FactorsSurvival RateFollow-Up StudiesFluorouracilRadiation PneumonitisRetrospective StudiesPrognosisNeoplasms, Radiation-InducedHead and Neck NeoplasmsRadiosurgeryRadiation-Sensitizing AgentsRadiometryBrain NeoplasmsDouble-Blind MethodAntineoplastic AgentsChemoradiotherapyCarcinoma, Squamous CellAdministration, OralRadiation Injuries, ExperimentalAluminum HydroxideAntineoplastic Agents, HormonalNasopharyngeal NeoplasmsNeoplasmsGamma RaysLung NeoplasmsTamoxifenParticle AcceleratorsRadiation-Protective AgentsDrug Administration ScheduleCyclophosphamideRadiodermatitisOrgans at RiskNeoadjuvant TherapyLymphatic MetastasisMastectomy, SegmentalDose-Response Relationship, DrugProspective StudiesCranial IrradiationCosmic RadiationMice, Inbred BALB CTomography, X-Ray ComputedImmunizationKaplan-Meier EstimateMastectomyCobalt RadioisotopesDacarbazineDoxorubicinClinical Trials as TopicNeoplasms, Second PrimaryVincristineBackground RadiationAdministration, IntranasalProstatic NeoplasmsCarcinoma, Non-Small-Cell LungMethotrexateRandomized Controlled Trials as TopicLaryngeal NeoplasmsVaccinesHodgkin DiseaseDrug Therapy, CombinationGlioblastoma